Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Fiona Douglas

Newcastle AuthorsTitleYearFull text
Dr Fiona Douglas
Kate Bailey
Analysis of rare disruptive germline mutations in 2135 enriched BRCA-negative breast cancers excludes additional high-impact susceptibility genes2022
Dr Fiona Douglas
Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival after Radical Treatment for Localised Prostate Cancer2015
Dr Fiona Douglas
Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers2014
Dr Fiona Douglas
Cancer risk and genotype-phenotype correlations in PTEN hamartoma tumor syndrome2014
Dr Fiona Douglas
DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers2014
Dr Fiona Douglas
Lymphocyte Telomere Length Is Long in BRCA1 and BRCA2 Mutation Carriers Regardless of Cancer-Affected Status2014
Professor Neil Rajan
Dr Piotr Pieniazek
Paul Hainsworth
Dr Fiona Douglas
Professor Ruth Plummer
Mesenteric cysts in Gorlin syndrome: a mimic of metastatic disease2014
Dr Fiona Douglas
Alexander Henderson
Penny Wilson
Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: Results from the initial screening round of the IMPACT study2014
Dr Fiona Douglas
Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk2013
Dr Fiona Douglas
Alexander Henderson
Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer2013
Professor Kofi Oppong
Dr Paul Brennan
Dr Fiona Douglas
Richard Charnley
Pancreatic Cancer Screening - are we doing it right?2013
Dr Fiona Douglas
Role of Engrailed-2 (EN2) as a prostate cancer detection biomarker in genetically high risk men2013
Dr Fiona Douglas
Breast Cancer Risk and 6q22.33: Combined Results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/22012
Dr Fiona Douglas
Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers2012
Dr Fiona Douglas
Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers2012
1234